Nosopharm, a company dedicated to the research and development of new anti-infective drugs, has named Jacques Biton as its new chairman of the board, taking over from Gilles Alberici.
At the CPhI Worldwide in Frankfurt, the winners of the 2019 Pharma awards were announced. The CEO of WuXi AppTec, Dr. Ge Li, received the award in category CEO of the year among 12 other categories.
A drug combo breaking antibiotic resistance of Gram-negative priority pathogens has been selected under the ENABLE programme of the Innovative Medicines Initiative (IMI).
Swiss specialty pharmaceutical company Santhera has named Dario Eklund as new CEO. Eklund joins from Vifor Pharma, where he served as Chief Commercial Officer.
/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png00h.genrich/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngh.genrich2019-11-06 07:50:002019-11-06 07:50:00Santhera nabs CEO from Vifor
Bergen Bio ASA’s Axl kinase blocker bemcentinib in combination with MSD’s pembrolizumab has met the primary endpoint in a Phase II study in patients with non small cell lung cancer (NSCLC).
German researchers have designed a modified Sleeping Beauty transposase that can be used for non-viral, stable and efficient gene insertions for gene and CAR-T therapies.
https://european-biotechnology.com/wp-content/uploads/2024/04/Transposase.jpg425620Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2019-11-05 07:13:312019-11-05 07:13:31Transposase makes CAR-T production cheaper
https://european-biotechnology.com/wp-content/uploads/2024/04/2019_11_05_staphyllo_sw.jpg540960Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2019-11-05 06:21:182024-04-02 16:20:39New players to step into the AMR field
Renowned immunologist Iain McInnes has been appointed to the Scientific Advisory Boar of Oxford BioDynamics Plc, where he joins Karol Sikora, Jane Mellor and Lucien Peng-Jin Ooi.
Breast cancer might be detected up to five years before there are any clinical signs of it, using a blood test that identifies the body’s immune response to substances produced by tumour cells.
https://european-biotechnology.com/wp-content/uploads/2024/04/breast_cancer_NCI.jpg611600Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2019-11-04 06:58:282019-11-04 06:58:28Test detects breast cancer in earliest stage
SciRhom targets autoimmunity switch
Latest NewsAutoimmunity specialist SciRhom GmbH has kicked of a first-in-class antibody development programme targeting iRhom2.
Nosopharm: Chair with experience
AppointmentsNosopharm, a company dedicated to the research and development of new anti-infective drugs, has named Jacques Biton as its new chairman of the board, taking over from Gilles Alberici.
CPhI: The Pharma Awards winners
Sponsored PublicationsAt the CPhI Worldwide in Frankfurt, the winners of the 2019 Pharma awards were announced. The CEO of WuXi AppTec, Dr. Ge Li, received the award in category CEO of the year among 12 other categories.
AMR: ENABLE selects Mutabilis candidate
Latest NewsA drug combo breaking antibiotic resistance of Gram-negative priority pathogens has been selected under the ENABLE programme of the Innovative Medicines Initiative (IMI).
Santhera nabs CEO from Vifor
AppointmentsSwiss specialty pharmaceutical company Santhera has named Dario Eklund as new CEO. Eklund joins from Vifor Pharma, where he served as Chief Commercial Officer.
NSCLC: Bemcentinib + anti-PD1 triple PFS
Latest NewsBergen Bio ASA’s Axl kinase blocker bemcentinib in combination with MSD’s pembrolizumab has met the primary endpoint in a Phase II study in patients with non small cell lung cancer (NSCLC).
Transposase makes CAR-T production cheaper
Latest NewsGerman researchers have designed a modified Sleeping Beauty transposase that can be used for non-viral, stable and efficient gene insertions for gene and CAR-T therapies.
New players to step into the AMR field
BackgroundDespite challenging markets new players are entering the field to advance drug development in the fight against antimicrobial resistance.
Oxford BioDynamics: Decorated board member
AppointmentsRenowned immunologist Iain McInnes has been appointed to the Scientific Advisory Boar of Oxford BioDynamics Plc, where he joins Karol Sikora, Jane Mellor and Lucien Peng-Jin Ooi.
Test detects breast cancer in earliest stage
Latest News